Venture Certified
| 기술평가보증기업(기금) | 2019-07-15 ~ 2021-07-14 | 20190108162 | 2019-07-15 |
| 혁신성장유형 | 2021-07-15 ~ 2024-07-14 | 20210818030069 | 2019-07-15 |
| 혁신성장유형 | 2024-07-15 ~ 2027-07-14 | 20240813030091 | 2019-07-15 |
Revenue CAGR +10.0%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 20B | 18B | 16B |
| Operating Profit | 0.2B | -0.3B | -0.1B |
| Net Profit | 0.1B | 0.1B | 0.0B |
| Total Assets | 15B | 13B | 13B |
| Total Liabilities | 11B | 9.6B | 9.5B |
| Total Equity | 3.8B | 3.3B | 3.2B |
▲ 15.1%
▲ 208.2%
▲ 196.2%
▲ 1.5%
▼ 29.2%
| Name | Position | Role |
|---|---|---|
| 박기웅 , 김혜영 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전광역시 유성구",
"ceo_name": "박기웅 , 김혜영",
"certificate": [
{
"cert_number": "20190108162",
"changes": "",
"disclosure_date": "2019-07-15",
"first_cert_date": "2019-07-15",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2019-07-15 ~ 2021-07-14"
},
{
"cert_number": "20210818030069",
"changes": "",
"disclosure_date": "2021-08-18",
"first_cert_date": "2019-07-15",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2021-07-15 ~ 2024-07-14"
},
{
"cert_number": "20240813030091",
"changes": "소재지",
"disclosure_date": "2024-08-13",
"first_cert_date": "2019-07-15",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2024-07-15 ~ 2027-07-14"
}
],
"company_name": "㈜대승바이오팜",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 300000000,
"cost_of_sales": 0,
"current_assets": 167275000,
"current_liabilities": 146118000,
"gross_profit": 1611717000,
"net_income": 3970000,
"net_income_bs": 3533000,
"non_current_assets": 1101588000,
"non_current_liabilities": 801000000,
"non_operating_expenses": 13187000,
"non_operating_income": 26147000,
"operating_profit": -8990000,
"revenue": 1611717000,
"sga_expenses": 1620707000,
"total_assets": 1268863000,
"total_equity": 321745000,
"total_liabilities": 947118000
},
"2023": {
"capital_stock": 300000000,
"cost_of_sales": 0,
"current_assets": 103049000,
"current_liabilities": 165236000,
"gross_profit": 1777062000,
"net_income": 10569000,
"net_income_bs": 10400000,
"non_current_assets": 1185132000,
"non_current_liabilities": 790800000,
"non_operating_expenses": 27293000,
"non_operating_income": 66155000,
"operating_profit": -28293000,
"revenue": 1777062000,
"sga_expenses": 1805355000,
"total_assets": 1288181000,
"total_equity": 332145000,
"total_liabilities": 956036000
},
"2024": {
"capital_stock": 340000000,
"cost_of_sales": 0,
"current_assets": 318313000,
"current_liabilities": 151420000,
"gross_profit": 1950667000,
"net_income": 5885000,
"net_income_bs": 4161000,
"non_current_assets": 1170012000,
"non_current_liabilities": 960600000,
"non_operating_expenses": 25050000,
"non_operating_income": 10762000,
"operating_profit": 20173000,
"revenue": 1950667000,
"sga_expenses": 1930494000,
"total_assets": 1488325000,
"total_equity": 376305000,
"total_liabilities": 1112020000
}
},
"industry": "농림수산학 및 수의학 연구개발업",
"investment": [],
"main_products": "친환경 유기농자재",
"phone": "042-826-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |